Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results , but sales fell by 10.3% year on year to $165 million.

The Plant and Animal Genomics conference recently held in San Diego showcased the ways that rapidly advancing technologies can be used in the crop and livestock sectors ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism ...

Sequencing volumes continue to grow in research and are growing rapidly in clinical applications, with the key drivers including whole-genome sequencing, cancer testing, and recurrence monitoring.

Humanity Protocol is partnering with genomics company Prenetics, to collaborate on blockchain-based identity verification and ...

The strategy is backed with $175.1 million CAD in federal funding to be dispensed over the next seven years through ...

Canada's researchers, businesses and institutions are at the forefront of the genomics revolution, unlocking the potential of this transformative science to drive innovation across industries, address ...